Skip to main content

Breadcrumb

  1. Home

Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC)

A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about A phase II single-arm, open-label trial of T-DM1 (ado-trastuzumab emtansine) and neratinib for HER2-positive breast cancer with molecular residual disease (KAN-HER2 MRD)

LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer

Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Circulating tumor DNA (ctDNA) monitoring in breast cancer patients receiving neoadjuvant palbociclib and endocrine therapy. A secondary analysis of the NeoRHEA phase 2 study

Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Optimization of an Integrated MultiOmyx-RNAscopehyperplexassay for co-detection and characterization of multiple protein and RNA biomarkers within the tumor microenvironment (TME)

High-throughput analysis of immune biomarkers from brightfield whole tumor images using IndicaHALO®

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about High-throughput analysis of immune biomarkers from brightfield whole tumor images using IndicaHALO®

Spatial characterization of pro-inflammatory pathways in the pathogenesis of IBD associated colorectal cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial characterization of pro-inflammatory pathways in the pathogenesis of IBD associated colorectal cancer

Molecular profiling of patients with colorectal cancer and their clinical implications

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Molecular profiling of patients with colorectal cancer and their clinical implications

Optimizing Read Depth With Real-World Sequencing Data in a Clinical Setting

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Optimizing Read Depth With Real-World Sequencing Data in a Clinical Setting

Microsatellite Instability (MSI) detection with TrueMark™ Assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Microsatellite Instability (MSI) detection with TrueMark™ Assay

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • …
  • Next page Next
  • Last page Last
Subscribe to